Recent Articles

• 
  AI Healthcare

  Stanford’s Lee Jinhyung Wins Edison Award for AI Brain Diagnosis

  Professor Lee Jin-hyung of Stanford University in the United States (in the photo) has developed an artificial intelligence (AI) brain diagnostic platform, “Neuromatch,” which has been selected as a winner of the Edison Awards, often called the “Oscars of Innovation.” The Edison Awards judging commi

  2026.01.27
• 
  Medical / Clinical Case

  Mother’s Liver, Stem Cell Transplant Saves Rare-Disease Child

  On the 13th, Professor Kim Hye-ri (right) of the Division of Pediatric Hematology and Oncology at Asan Medical Center in Seoul examines 13-year-old Yoo Eun-seo, who successfully received a liver and hematopoietic stem cells from her mother and has been able to discontinue immunosuppressants. Provide

  2026.01.26
• 
  Medical / Medical AI

  Stanford’s Lee Jin-hyung Wins Edison Award for AI Brain Diagnosis Platform

  An artificial intelligence (AI) brain diagnosis platform called “Neuromatch,” developed by Professor Jinhyung Lee of Stanford University in the United States, has been selected as a winner of the Edison Awards, often referred to as the “Oscars of Innovation.” The Edison Awards judging committee anno

  2026.01.26
• 
  Medical / Medical AI & Semiconductor

  Deepnoid, FuriosaAI Partner to Speed Medical AI Innovation

  The first-generation medical AI specialist Deepnoid has signed a memorandum of understanding (MOU) with domestic AI semiconductor company FuriosaAI and will begin commercial operation of AI semiconductors. Deepnoid was founded in 2008 and was listed on KOSDAQ in 2021 under the special listing regime

  2026.01.26
• 
  Medical / Research

  Scientists Find Fat Cell ‘Switch,’ Paving Way for Precise Obesity, Fatty Liver Treatments

  Getty Images Bank With the emergence of obesity treatments that can be taken as pills instead of injections, interest in obesity treatment is growing even hotter in Korea. The obesity treatments known as “Wegovy” and “Mounjaro” belong to the glucagon-like peptide-1 (GLP-1) class. GLP-1-based obesity

  2026.01.26
• 
  Pharmaceutical R&D

  Universal Blood Type Developed, Surpassing Donation Limits

  On January 13, Artblood CEO Baek Eun-jung (Professor of Laboratory Medicine at Hanyang University Hospital) points to a container filled with rapidly proliferating red blood cells at the company’s research institute in Seocho-gu, Seoul, explaining the technology for cell line-based artificial red bl

  2026.01.24
• 
  Pharmaceutical R&D

  SK Bioscience Completes Global R&PD Center in Songdo

  Panoramic view of SK bioscience’s Global R&PD Center. Courtesy of SK bioscience SK bioscience announced on the 23rd that it has completed its “Global R&PD Center” in Songdo International City, Yeonsu-gu, Incheon.The center was established to develop the Songdo bio cluster into an advanced research-b

  2026.01.23
• 
  MedTech

  Ultra V Plant 2 Gains KGMP Nod, Boosts UltaCol Output

  Photo provided by UltraV Global bio-medical beauty group UltraV (UltraV, CEO Kwon Han-jin) has obtained certification for the Good Manufacturing Practice for Medical Devices and Quality Management (KGMP) for its Hyangdong plant and has commenced operation of a second manufacturing site to expand pro

  2026.01.23
• 
  Medical / Clinical Case

  Sarangi Women’s Clinic Reports Implantation After BSC Procedure

  Director Park Joo-hee of Sarang-i Women’s Clinic. Provided by Sarang-i Women’s Clinic Director Park Joo-hee of Sarang-i Women’s Clinic, a medical institution specializing in infertility clinics, stated on the 23rd that she had observed cases in which embryo implantation was confirmed during in vitro

  2026.01.23
• 
  Biotech

  K-Run, Osong Foundation, Young Science Sign Nucleic Acid Therapy GMP Infrastructure Deal

  (From left) Young Science CEO Jung Tae-hoon, Osong Foundation Biopharmaceutical Production Center Director Kim Hyun-il, and K-Run CEO Han Cheong-su signed a three-party agreement. Photo provided by Osong Medical Innovation Foundation K-Run Co., Ltd. (CEO Han Cheong-su) announced that on the 20th it

  2026.01.23